# Medi-Caps (NSE: MEDICAPQ) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MEDICAPQ · Pivot · prices to 21 Oct 2026

Medi-Caps (NSE: MEDICAPQ) closed at ₹25.50 on 21 Oct 2026. With a market capitalisation of ₹32 Cr, it ranks 3341st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Real Estate - Diversified.

Its return on equity was −2.7% in FY26. Its 52-week range is ₹20.33 (18 Aug 2026) to ₹36.80 (10 Sep 2026); the last close is 30.7% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹3 Cr (+3.7% year on year) and net profit −₹2 Cr, on a consolidated basis. Promoters held 51.44% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹25.50 |
| Market cap | ₹32 Cr |
| ROE | −2.7% (FY26) |
| ROCE | −2.7% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹36.80 (10 Sep 2026) |
| 52-week low | ₹20.33 (18 Aug 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹3 Cr | +3.7% | −₹2 Cr | — | −₹1.79 |
| Q4 FY26 | ₹3 Cr | −50.3% | ₹3 Cr | +76.7% | ₹2.44 |
| Q3 FY26 | ₹4 Cr | +7.0% | −₹1 Cr | — | −₹0.61 |
| Q2 FY26 | ₹2 Cr | −75.8% | −₹2 Cr | −687.1% | −₹1.46 |
| Q1 FY26 | ₹3 Cr | −56.5% | −₹3 Cr | — | −₹2.80 |
| Q4 FY25 | ₹7 Cr | −11.8% | ₹2 Cr | — | ₹1.38 |
| Q3 FY25 | ₹4 Cr | −43.1% | −₹2 Cr | — | −₹1.64 |
| Q2 FY25 | ₹8 Cr | +37.6% | ₹0 Cr | +158.3% | ₹0.25 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹25 Cr | −₹1 Cr |
| FY24 | ₹27 Cr | −₹2 Cr |
| FY23 | ₹49 Cr | ₹2 Cr |
| FY22 | ₹70 Cr | ₹10 Cr |
| FY21 | ₹57 Cr | ₹11 Cr |
| FY20 | ₹43 Cr | −₹6 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 51.44%
- Domestic institutions: 0.02%
- Non-institutions: 48.54%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [JFL Life Scienc](https://app.pivotnow.in/stock/JFLLIFE) | ₹10.30 | ₹34 Cr | 0.2 | — |
| [Chandra Bhagat](https://app.pivotnow.in/stock/CBPL) | — | ₹33 Cr | — | — |
| [Sharma East Ind](https://app.pivotnow.in/stock/SHARMEH) | — | ₹33 Cr | — | — |
| [Deccan Health C](https://app.pivotnow.in/stock/DECCAN) | — | ₹32 Cr | — | — |
| [KK Shah Hospita](https://app.pivotnow.in/stock/KKSHL) | — | ₹30 Cr | — | — |
| [Panjon](https://app.pivotnow.in/stock/PANJON) | — | ₹30 Cr | — | — |

## Questions and answers

### What is the share price of Medi-Caps today?

Medi-Caps (NSE: MEDICAPQ) last closed at ₹25.50 on 21 Oct 2026. Its 52-week high is ₹36.80 and its 52-week low is ₹20.33.

### What is the market cap of Medi-Caps?

Medi-Caps' market capitalisation is ₹32 Cr (₹32 Cr) at the 22 Oct 2026 close, ranking 3341st among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Medi-Caps?

Return on equity was −2.7% in FY26 and return on capital employed was −2.7% in FY26 (consolidated figures).

### Is Medi-Caps a debt-free company?

Medi-Caps is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Medi-Caps' latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Medi-Caps reported revenue of ₹3 Cr, +3.7% year on year, and net profit of −₹2 Cr.

### What is the shareholding pattern of Medi-Caps?

As of 30 Jun 2026: promoters 51.44%, domestic institutions 0.02%, non-institutions 48.54%.

### Who are Medi-Caps' competitors?

The listed Pharma & Healthcare companies closest to Medi-Caps by market cap are JFL Life Scienc, Chandra Bhagat, Sharma East Ind, Deccan Health C, KK Shah Hospita and Panjon.

### Is Medi-Caps a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Medi-Caps' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MEDICAPQ against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.